National Assembly Opposition Leader Omar Ayub said on Thursday that the Pakistan Tehreek-e-Insaf had condemned the Balochistan Liberation Army. Speaking to media in Peshawar, Ayub said: "The meeting ...

FDA priority review of pz-cel Biologics License Application (BLA) progressing with Prescription Drug User Fee Act (PDUFA) ...

TECELRA® launch momentum accelerating – 10 patients apheresed in Q1 2025 and 3 in 2024; 20 ATCs available; all manufacturing and supply goals ...

A stranded loggerhead sea turtle (Caretta caretta) discovered on a Danish beach in January has been given a second chance at ...

Announced the U.S. FDA has accepted our Biologics License Application (BLA) seeking full approval of deramiocel for the treatment of Duchenne muscular dystrophy (DMD) cardiomyopathyBLA granted priorit ...

FDA granted priority review to Company's BLA for PRGN-2012 for the treatment of adults with recurrent respiratory papillomatosis and set PDUFA target action date ...

The BLA is reportedly mulling launching a major attack on the China-Pakistan Economic Corridor (CPEC) being developed in ...

The Balochistan Liberation Army (BLA) is eyeing the nuclear weapons of Pakistan after giving a jolt by hijacking the Jaffar Express which claimed several lives in the incident. The Pakistan Army and ...

After two days of intense military operations, 33 attackers were killed, and 26 passengers — including 18 army and FC ...

INmune Bio's high-upside potential with CORDStrom for RDEB and XPro for Alzheimer's, offering up to 144.8x returns. Click ...

The table is a review of notable updates that occurred in February 2025 for investigational products in development.

Significant progress was made in 2024, including refining the Phase 3 program to accelerate rilparencel’s path to market in the U.S., the release ...